Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Infectious Disease
100%
Infection
98%
Real Time Polymerase Chain Reaction
49%
Nontuberculous mycobacteria
47%
Severe Acute Respiratory Syndrome Coronavirus 2
45%
COVID-19
42%
Mycobacterium avium complex
41%
Lung
37%
Mycobacterium abscessus
35%
Influenza
26%
Susceptibility
25%
Minimum Inhibitory Concentration
24%
Ribosomal RNA
22%
Antibiotic Sensitivity
22%
Drug Sensitivity
21%
Mycobacteria
20%
Mycobacterium Tuberculosis
17%
Antimicrobial Agent
17%
Ribosome RNA
17%
Virus
17%
Multilocus Sequence Typing
17%
Respiratory Virus
16%
Klebsiella pneumoniae
15%
Infectious Agent
15%
Enterococcus faecium
15%
Human respiratory syncytial virus
15%
Antigen
15%
In Vitro
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Enterococcus
11%
Matrix-Assisted Laser Desorption-Ionization
11%
Broth Dilution
11%
Mycobacterium tuberculosis complex
10%
Gram-Negative Bacteria
10%
Drug Resistance
10%
Vancomycin-Resistant Enterococcus
10%
Sputum
10%
Reverse Transcription Polymerase Chain Reaction
9%
Plasmid
8%
Cohort Effect
8%
Cross-Reactivity
8%
Immunoassay
8%
Type Strain
8%
Viral Load
8%
Antibiotic Resistance
8%
Species Identification
7%
Microorganism
7%
Time-of-Flight Mass Spectrometry
7%
Middle East Respiratory Syndrome Coronavirus
7%
Multi-Drug-Resistant Tuberculosis
7%
Medicine and Dentistry
Silo-Filler's Disease
80%
Mycobacterium avium complex
36%
COVID-19
31%
Treatment Outcome
28%
Macrolide
28%
Antibiotic Therapy
25%
Mycobacterium abscessus
23%
Rifampicin
19%
Infection
18%
Diseases
17%
Lung Tuberculosis
16%
Multidrug Resistant Tuberculosis
15%
Sputum
15%
Mycobacterium Tuberculosis
14%
Tuberculosis
13%
Quinolone Derivative
12%
Acid Fast Bacterium
12%
Middle East Respiratory Syndrome Coronavirus
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Isoniazid
11%
Laboratory Diagnosis
11%
Middle East Respiratory Syndrome
11%
Polymerase Chain Reaction
11%
Sputum Culture
10%
Atypical Mycobacterium
10%
Ethambutol
10%
Drug Sensitivity
10%
Culture Conversion
9%
Pathogen
9%
Bronchiectasis
9%
Pneumonia
9%
Immunocompromised Patient
9%
Mixed Infection
8%
Amikacin
8%
Bloodstream Infection
8%
Mycobacterium kansasii
8%
Mycobacterium massiliense
7%
Clinical Significance
7%
Tuberculous Lymphadenitis
7%
Linezolid
7%
Endobronchial Ultrasonography
7%
Infectious Disease
7%
Transbronchial Aspiration
7%
Clinical Feature
7%
Antigen
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Antimicrobial Agent
6%
Reinfection
6%
Cohort Effect
6%
Antibiotics
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
29%
Lung Disease
19%
Mycobacterium avium complex
15%
Infection
11%
Enterococcus faecium
11%
Diseases
11%
Vancomycin
9%
Antimicrobial Agent
8%
Mycobacterium abscessus
7%
Linezolid
7%
Macrolide
7%
Tuberculosis
7%
Immunocompromised Patient
6%
Clinical Feature
6%
Febrile Neutropenia
6%
Coronavirinae
6%
Hematologic Malignancy
6%
Lung Tuberculosis
5%
Antigen
5%